# OnCo record tln-121 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/tln-121/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "tln-121" ;
  schema:name "TLN-121"@en ;
  schema:description "TLN-121 is an experimental protein degrader from Treeline Biosciences, in phase 1 trials for B-cell lymphoma, T-cell lymphoma and non-Hodgkin lymphoma."@en ;
  schema:url <https://onco.cc/drugs/tln-121/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://treeline.bio/medicines>, <https://treeline.bio/medicines>, <https://clinicaltrials.gov/search?intr=TLN-121> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Protein degrader (small molecule)" ;
  onco:cancers <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:targets <https://onco.cc/targets/bcl6/> ;
  onco:companies <https://onco.cc/companies/treeline-biosciences/> ;
  onco:trials <https://onco.cc/trials/nct07082803/> .